Janus Henderson Global Life Sciences Fund

Frequently Asked Questions About JFNIX

What does JFNIX invest in?

The fund primarily aims to achieve its investment objectives by allocating a minimum of 80% of its net capital (which may include funds borrowed for investment purposes) to securities of companies that its portfolio manager identifies as having a strong orientation towards life sciences. Additionally, as a core principle, the fund generally pledges to invest at least 25% of its overall assets in businesses specifically categorized within the "life sciences" sector.

What is the expense ratio of JFNIX?

Janus Henderson Global Life Sciences Fund (JFNIX) charges an expense ratio of 0.78%. This is the annual fee deducted from fund assets to cover management and operations.

How big is JFNIX?

Janus Henderson Global Life Sciences Fund (JFNIX) manages $5.77B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation.

Is JFNIX actively managed or an index fund?

JFNIX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was JFNIX launched?

Janus Henderson Global Life Sciences Fund (JFNIX) launched in July 2009 and is managed by Janus Henderson.

How has JFNIX performed?

JFNIX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.